{"id":5086,"date":"2020-05-22T10:27:14","date_gmt":"2020-05-22T14:27:14","guid":{"rendered":"http:\/\/blogs.cdc.gov\/genomics\/?p=5086"},"modified":"2024-04-09T16:54:36","modified_gmt":"2024-04-09T20:54:36","slug":"genetic-counseling-3","status":"publish","type":"post","link":"https:\/\/blogs.cdc.gov\/genomics\/2020\/05\/22\/genetic-counseling-3\/","title":{"rendered":"Genetic Counseling in the Time of COVID-19"},"content":{"rendered":"<p><a href=\"https:\/\/blogs.cdc.gov\/wp-content\/uploads\/sites\/20\/2020\/05\/2020-4_blog_counseling_covid.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignright size-medium wp-image-5088\" src=\"https:\/\/blogs.cdc.gov\/wp-content\/uploads\/sites\/20\/2020\/05\/2020-4_blog_counseling_covid-300x169.jpg\" alt=\"a hand magnifying DNA on COVID-19 with cellphones, tablets and laptops being connected by figures\" width=\"300\" height=\"169\" srcset=\"https:\/\/blogs.cdc.gov\/genomics\/wp-content\/uploads\/sites\/20\/2020\/05\/2020-4_blog_counseling_covid-300x169.jpg 300w, https:\/\/blogs.cdc.gov\/genomics\/wp-content\/uploads\/sites\/20\/2020\/05\/2020-4_blog_counseling_covid.jpg 457w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a><a href=\"https:\/\/blogs.cdc.gov\/genomics\/2018\/12\/28\/what-is-genetic-counseling\/\"><span style=\"font-family: 'Times New Roman',serif; font-size: 12pt;\">Genetic counselors<\/span><\/a><span style=\"font-family: 'Times New Roman',serif; font-size: 12pt;\"><span style=\"color: #000000;\"> play an important role in clinical genetics by helping patients understand their genetic health risks. Due to the COVID-19 pandemic, most clinics and hospitals have restricted in-person delivery of non-essential healthcare services, including genetic counseling, to slow the spread of the virus. However, delaying genetic counseling can be problematic, for example, when genetic testing would affect decisions during a pregnancy or about cancer treatment. Moreover, genetics and genetic counseling have become integral to healthcare as we learn more and more about genetic risks for disease.<\/span><\/span><\/p>\n<p><span style=\"font-family: 'Times New Roman',serif; font-size: 12pt;\"><span style=\"color: #000000;\">Now that genetic counselors are largely unable to see patients in person due to the COVID-19 pandemic, more genetic counselors are <\/span><\/span><span style=\"font-family: 'Times New Roman',serif; font-size: 12pt;\">turning to telehealth<\/span><span style=\"font-family: 'Times New Roman',serif; font-size: 12pt;\"><span style=\"color: #000000;\"> out of necessity. <\/span><\/span><a href=\"https:\/\/www.hrsa.gov\/rural-health\/telehealth\"><span style=\"font-family: 'Times New Roman',serif; font-size: 12pt;\">Telehealth<\/span><\/a><span style=\"font-family: 'Times New Roman',serif; font-size: 12pt;\"><span style=\"color: #000000;\"> refers to the use of technology to support long-distance healthcare. For example, instead of an office visit, a patient could video chat with a healthcare provider. Many clinics that used a mixture of in-person and telehealth services in the past have now transitioned to using only telehealth services due to the pandemic. However, for clinics that have only seen patients in-person, the transition to using telehealth may present a challenge. Private genetic counseling companies that offer genetic counseling exclusively through telehealth may be able to provide guidance to other genetic counselors or healthcare professionals on how technology can be used to communicate with patients, deliver results, and provide support to patients during this time. <\/span><\/span><\/p>\n<p><span style=\"font-family: 'Times New Roman',serif; font-size: 12pt;\"><span style=\"color: #000000;\">Because of the increased need for telehealth during the COVID-19 pandemic, insurance coverage of distance-based services has become increasingly important. While the Centers for Medicare and Medicaid Services (CMS) has recently <\/span><\/span><a href=\"https:\/\/www.cms.gov\/newsroom\/press-releases\/president-trump-expands-telehealth-benefits-medicare-beneficiaries-during-covid-19-outbreak\"><span style=\"font-family: 'Times New Roman',serif; font-size: 12pt;\">expanded telehealth benefits<\/span><\/a><span style=\"font-family: 'Times New Roman',serif; font-size: 12pt;\"><span style=\"color: #000000;\"> for Medicare beneficiaries, they do not presently recognize genetic counselors as healthcare providers. This means that genetic counselors cannot be reimbursed for their services or see Medicare recipients without a physician present, which presents challenges to providing genetic counseling via telehealth. To improve Medicare recipients\u2019 access to genetic counseling during the COVID-pandemic, the National Society of Genetic Counselors (NSGC) has issued a <\/span><\/span><span style=\"font-family: 'Times New Roman',serif; font-size: 12pt;\">statement<\/span><span style=\"font-family: 'Times New Roman',serif; font-size: 12pt;\"><span style=\"color: #000000;\"> offering some potential short- and long-term solutions. <\/span><\/span><\/p>\n<p><span style=\"font-family: 'Times New Roman',serif; font-size: 12pt;\"><span style=\"color: #000000;\">Thinking ahead to post-pandemic life, telehealth may be used more commonly in genetic counseling in the future. Genetic counselors had used telehealth services <\/span><\/span><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29512937\/\"><span style=\"font-family: 'Times New Roman',serif; font-size: 12pt;\">long before the pandemic<\/span><\/a><span style=\"font-family: 'Times New Roman',serif; font-size: 12pt;\"><span style=\"color: #000000;\">, and there is a trend showing that the <\/span><\/span><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32314856\/\"><span style=\"font-family: 'Times New Roman',serif; font-size: 12pt;\">use of these services has grown<\/span><\/a><span style=\"font-family: 'Times New Roman',serif; font-size: 12pt;\"><span style=\"color: #000000;\"> over the past few years. Some healthcare professionals have had <\/span><\/span><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27987158\/\"><span style=\"font-family: 'Times New Roman',serif; font-size: 12pt;\">concerns<\/span><\/a><span style=\"font-family: 'Times New Roman',serif; font-size: 12pt;\"><span style=\"color: #000000;\"> about using telehealth, such as the possibility for technical difficulties, privacy concerns, decreased ability to interpret non-verbal cues, and decreased rapport-building. However, studies have shown that patient satisfaction with telehealth genetic counseling services is <\/span><\/span><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4865495\/\"><span style=\"font-family: 'Times New Roman',serif; font-size: 12pt;\">high<\/span><\/a><span style=\"font-family: 'Times New Roman',serif; font-size: 12pt;\"><span style=\"color: #000000;\">. Telehealth has the potential to improve access to services, which is a major benefit in a field where there is a high and growing demand for genetics services. Many genetic counselors consider telehealth to be <\/span><\/span><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26762366\/\"><span style=\"font-family: 'Times New Roman',serif; font-size: 12pt;\">more convenient<\/span><\/a><span style=\"font-family: 'Times New Roman',serif; font-size: 12pt;\"><span style=\"color: #000000;\"> than traditional in-person service delivery due to reduced travel times and wait times for patients. In these uncertain times, one thing that seems certain is that telehealth in genetic counseling is here to stay.<\/span><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Genetic counselors play an important role in clinical genetics by helping patients understand their genetic health risks. Due to the COVID-19 pandemic, most clinics and hospitals have restricted in-person delivery of non-essential healthcare services, including genetic counseling, to slow the spread of the virus. However, delaying genetic counseling can be problematic, for example, when genetic<\/p>\n","protected":false},"author":122,"featured_media":5088,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[31870,5236],"tags":[61966,62376],"_links":{"self":[{"href":"https:\/\/blogs.cdc.gov\/genomics\/wp-json\/wp\/v2\/posts\/5086"}],"collection":[{"href":"https:\/\/blogs.cdc.gov\/genomics\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.cdc.gov\/genomics\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.cdc.gov\/genomics\/wp-json\/wp\/v2\/users\/122"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.cdc.gov\/genomics\/wp-json\/wp\/v2\/comments?post=5086"}],"version-history":[{"count":6,"href":"https:\/\/blogs.cdc.gov\/genomics\/wp-json\/wp\/v2\/posts\/5086\/revisions"}],"predecessor-version":[{"id":6725,"href":"https:\/\/blogs.cdc.gov\/genomics\/wp-json\/wp\/v2\/posts\/5086\/revisions\/6725"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/blogs.cdc.gov\/genomics\/wp-json\/wp\/v2\/media\/5088"}],"wp:attachment":[{"href":"https:\/\/blogs.cdc.gov\/genomics\/wp-json\/wp\/v2\/media?parent=5086"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.cdc.gov\/genomics\/wp-json\/wp\/v2\/categories?post=5086"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.cdc.gov\/genomics\/wp-json\/wp\/v2\/tags?post=5086"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}